NO305204B1 - Oksazolidin-2-on derivater - Google Patents

Oksazolidin-2-on derivater

Info

Publication number
NO305204B1
NO305204B1 NO944802A NO944802A NO305204B1 NO 305204 B1 NO305204 B1 NO 305204B1 NO 944802 A NO944802 A NO 944802A NO 944802 A NO944802 A NO 944802A NO 305204 B1 NO305204 B1 NO 305204B1
Authority
NO
Norway
Prior art keywords
lower alkyl
hydrogen
nitrile
phenyl
coch3
Prior art date
Application number
NO944802A
Other languages
English (en)
Norwegian (no)
Other versions
NO944802L (no
NO944802D0 (no
Inventor
Janos Borgulya
Hans Bruderer
Roland Jakob-Roetne
Stephan Roever
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO944802D0 publication Critical patent/NO944802D0/no
Publication of NO944802L publication Critical patent/NO944802L/no
Publication of NO305204B1 publication Critical patent/NO305204B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/24Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO944802A 1993-12-13 1994-12-12 Oksazolidin-2-on derivater NO305204B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH370193 1993-12-13
CH292794 1994-09-27

Publications (3)

Publication Number Publication Date
NO944802D0 NO944802D0 (no) 1994-12-12
NO944802L NO944802L (no) 1995-06-14
NO305204B1 true NO305204B1 (no) 1999-04-19

Family

ID=25691748

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944802A NO305204B1 (no) 1993-12-13 1994-12-12 Oksazolidin-2-on derivater

Country Status (21)

Country Link
US (1) US5574055A (pt)
EP (1) EP0657440B1 (pt)
JP (1) JP2602635B2 (pt)
KR (1) KR100362295B1 (pt)
CN (1) CN1051308C (pt)
AT (1) ATE191480T1 (pt)
AU (1) AU684319B2 (pt)
CA (1) CA2135861A1 (pt)
CZ (1) CZ291030B6 (pt)
DE (1) DE59409270D1 (pt)
DK (1) DK0657440T3 (pt)
ES (1) ES2145087T3 (pt)
GR (1) GR3033815T3 (pt)
HU (1) HU221809B1 (pt)
IL (1) IL111890A (pt)
NO (1) NO305204B1 (pt)
NZ (1) NZ270083A (pt)
PT (1) PT657440E (pt)
RU (1) RU2133743C1 (pt)
TW (1) TW286317B (pt)
UA (1) UA44691C2 (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4332384A1 (de) * 1993-09-23 1995-03-30 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten III
FR2751653B1 (fr) * 1996-07-25 1998-09-04 Synthelabo Derives de 3-benzofuranyloxazolidin-2-one, leur procede de preparation et leur application en therapeutique
FR2751651B1 (fr) * 1996-07-25 1998-09-04 Synthelabo Derives de 3-(benzo[b]thien-3-yl)oxazolidin-2-one, leur procede de preparation et leur application en therapeutique
WO1997013768A1 (fr) * 1995-10-11 1997-04-17 Synthelabo Composes derives d'oxazolidin-2-one, leur procede de preparation et leur application en therapeutique
FR2739856B1 (fr) * 1995-10-11 1997-11-14 Synthelabo Derives de 3-benzofuranyloxazolidin-2-one, leur procede de preparation et leur application en therapeutique
DE19601265A1 (de) * 1996-01-16 1997-07-17 Bayer Ag 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone
DE19601264A1 (de) * 1996-01-16 1997-07-17 Bayer Ag Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone
DE19601627A1 (de) 1996-01-18 1997-07-24 Bayer Ag Heteroatomhaltige Cyclopentanopyridyl-Oxazolidinone
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
HRP970049A2 (en) * 1996-02-06 1998-04-30 Bayer Ag New heteroaryl oxazolidinones
DE19604223A1 (de) 1996-02-06 1997-08-07 Bayer Ag Neue substituierte Oxazolidinone
GB9702213D0 (en) 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
GB9609919D0 (en) 1996-05-11 1996-07-17 Zeneca Ltd Chemical compounds
JP3865450B2 (ja) * 1997-02-14 2007-01-10 田辺製薬株式会社 パーキンソニズム治療剤
GB9717807D0 (en) * 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9717804D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9725244D0 (en) 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds
CN1311787A (zh) 1998-06-05 2001-09-05 阿斯特拉曾尼卡有限公司 噁唑烷酮衍生物、其制备方法以及含有它们的药物组合物
GB9912417D0 (en) * 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
JP2004520432A (ja) * 2001-02-05 2004-07-08 ファルマシア・アンド・アップジョン・カンパニー オキサゾリジノン抗菌薬の直腸送達のための組成物
EP1448536A1 (en) * 2001-11-29 2004-08-25 Merck & Co., Inc. Cyclopropyl-containing oxazolidinone antibiotics and derivatives thereof
CA2530140C (en) 2003-07-02 2010-11-09 Merck & Co., Inc. Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
WO2005028467A1 (en) * 2003-09-15 2005-03-31 Anadys Pharmaceuticals, Inc. Antibacterial 3,5-diaminopiperidine-substitute aromatic and heteroaromatic compounds
WO2007102082A1 (en) * 2006-03-09 2007-09-13 Glenmark Pharmaceuticals Limited High oxazolidinone content solid dosage forms
CN103497173A (zh) 2006-03-31 2014-01-08 财团法人乙卯研究所 具有杂环的新化合物
AU2008258549B2 (en) 2007-06-08 2013-11-14 Janssen Pharmaceutica N.V. Piperidine/piperazine derivatives
WO2008148851A1 (en) * 2007-06-08 2008-12-11 Janssen Pharmaceutica N.V. Piperidine/piperazine derivatives
CA2687754C (en) * 2007-06-08 2015-12-08 Janssen Pharmaceutica N.V. Piperidine, piperazine derivatives for use as dgat inhibitors
JO2972B1 (en) * 2007-06-08 2016-03-15 جانسين فارماسوتيكا ان. في Piperidine / piperazine derivatives
WO2009044777A1 (ja) 2007-10-02 2009-04-09 Research Foundation Itsuu Laboratory 7員ヘテロ環を有するオキサゾリジノン誘導体
WO2009147170A2 (en) 2008-06-05 2009-12-10 Janssen Pharmaceutica Nv Drug combinations comprising a dgat inhibitor and a ppar-agonist

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1180089A (en) * 1967-10-20 1970-02-04 Delalande Sa Acetylenic Derivatives of 2-Oxazolidinones and processes of preparation
FR2356422A1 (fr) * 1976-03-01 1978-01-27 Delalande Sa Nouveaux hydroxymethyl-5 oxazolidinone-2, leur procede de preparation et leur application en therapeutique
FR2380780A2 (fr) * 1977-02-22 1978-09-15 Delalande Sa Application en therapeutique des hydroxymethyl-5 oxazolidinones-2, notamment comme antidepresseurs
LU80081A1 (fr) * 1977-08-26 1979-05-15 Delalande Sa Nouvelles hydroxymethyl-5 oxazolidinones-2,leur procede de preparation et leur application therapeutique
US4348393A (en) * 1978-06-09 1982-09-07 Delalande S.A. N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones
CA1171865A (en) * 1980-06-04 1984-07-31 Alain Lacour N-aryl azolone derivatives, the process for preparing the same and their application in therapeutics
FR2500450A1 (fr) * 1981-02-25 1982-08-27 Delalande Sa Nouveaux derives aminomethyl-5 oxazolidiniques, leur procede de preparation et leur application en therapeutique
US4461773A (en) * 1982-09-15 1984-07-24 E. I. Dupont De Nemours And Company P-Oxooxazolidinylbenzene compounds as antibacterial agents
US5254577A (en) * 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
FR2653017B1 (fr) * 1989-10-17 1995-05-05 Delalande Sa Derives d'aryl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique.
US5182296A (en) * 1989-10-26 1993-01-26 Tanabe Seiyaky Co., Ltd. Naphthyloxazolidone derivatives
ATE194981T1 (de) * 1992-04-30 2000-08-15 Taiho Pharmaceutical Co Ltd Oxazolidinderivat und sein pharmazeutisch verträgliches salz

Also Published As

Publication number Publication date
PT657440E (pt) 2000-09-29
KR100362295B1 (ko) 2003-03-03
CZ291030B6 (cs) 2002-12-11
JPH07196634A (ja) 1995-08-01
NZ270083A (en) 1996-02-27
IL111890A0 (en) 1995-03-15
DK0657440T3 (da) 2000-09-04
CN1109054A (zh) 1995-09-27
EP0657440A1 (de) 1995-06-14
TW286317B (pt) 1996-09-21
NO944802L (no) 1995-06-14
JP2602635B2 (ja) 1997-04-23
ATE191480T1 (de) 2000-04-15
CA2135861A1 (en) 1995-06-14
HUT72315A (en) 1996-04-29
RU2133743C1 (ru) 1999-07-27
IL111890A (en) 1998-12-06
AU684319B2 (en) 1997-12-11
NO944802D0 (no) 1994-12-12
DE59409270D1 (de) 2000-05-11
AU8023394A (en) 1995-06-22
HU9403494D0 (en) 1995-02-28
GR3033815T3 (en) 2000-10-31
CN1051308C (zh) 2000-04-12
US5574055A (en) 1996-11-12
CZ312694A3 (en) 1995-08-16
KR950017993A (ko) 1995-07-22
UA44691C2 (uk) 2002-03-15
RU94043806A (ru) 1996-10-27
EP0657440B1 (de) 2000-04-05
ES2145087T3 (es) 2000-07-01
HU221809B1 (hu) 2003-01-28

Similar Documents

Publication Publication Date Title
NO944802L (no) Oksazolidin-2-on derivater
PE59099A1 (es) Nuevos derivados del acido hexanoico
HUT61284A (en) Process for producing n-substituted heterocyclic compounds and pharmaceutical compositions comprising such compounds as active ingredient
MY102908A (en) Isoxazole and furan derivatives, their preparation and use as antiviral agents.
BR9500996A (pt) Derivado de difenila,agente terapêutico,processo para a preparação de um derivado de difenila,derivado de fenilpiperazina,composição farmacológica e métodos para fazer um medicamento e para tratar ou melhorar uma doença
DK0745063T3 (da) Substituerede biphenyl-derivater med phosphodiesterase-inhiberende virkning
ES2093332T3 (es) Nuevos derivados arilglicinamidicos, su procedimiento de preparacion y su uso para el tratamiento de la disuria.
ATE153666T1 (de) Phosphono-arylethanolamin-verbindungen mit antihyperglykämischer und/oder antiobeser wirkung
NO994659L (no) Nye pyridinderivater og farmasöytiske preparater inneholdende slike
JPS6429352A (en) Novel polycyclic aromatic compound, medicine and cosmetic composition
MX9405111A (es) Nuevos derivados de (1-fenil-1-heterociclil)metanol y(1-fenil-1-heterociclil-metilamina).
ES2002036A6 (es) Un procedimiento para la preparacion de derivados de dicloroanilina.
ATE162191T1 (de) Azanoradamantane
KR910006292A (ko) 방향족 산의 n-아자비시클로 [3.3.0] 옥탄 아미드
ES2098730T3 (es) Derivados de hidrazida de 3,4-dihidro-2h-1-benzopiranos.
RU1220298C (ru) Хлоргидрат о-бензоилоксима 1,2,5-триметилпиперидона-4, обладающий антагонистической активностью по отношению к морфину, промедолу и этанолу
ATE193204T1 (de) Präparat zur behandlung der drogenabhängigkeit

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees